Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Flaxseed Intervention Study to Assess Sex Hormone Levels Among Post-Menopausal Women

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Линкът е запазен в клипборда
СъстояниеЗавършен
Спонсори
Cancer Care Ontario
Сътрудници
Canadian Breast Cancer Foundation, Ontario Region (funder)
University of Toronto
York University, Institute for Social Research
Mount Sinai Services
Roswell Park Cancer Institute

Ключови думи

Резюме

The purpose of this study is to understand whether consuming flaxseed for approximately 50 days may beneficially affect the level of certain hormones in the blood thought to be involved in the development of breast cancer. This study will address the first steps toward the development of possible breast cancer prevention strategies. Differences in hormone levels (from blood samples) will be compared between two groups of women - those in the group assigned to eating ground flaxseed daily and those in the control group (with no change in diet).

Описание

PRIMARY OBJECTIVES:

I. Evaluate whether a dietary flaxseed intervention among post-menopausal women influences circulating levels of sex steroid hormones and estrogen metabolites (including estradiol, estrone, 2-hydroxy(OH)-/16-OH-estrone ratio, SHBG, testosterone, 2-MeOH-E1&-E2, 4-MeOH-E1&-E2) thought to be involved in the development of breast cancer.

SECONDARY OBJECTIVES:

II. Assess a) the effect of flaxseed intake on serum enterolignan levels (lignan biomarker), b) the relationship between serum enterolignan and sex hormone levels.

III. Describe adherence to the flaxseed intervention.

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM 1: Participants take 2 tablespoons of ground flaxseed daily for approximately 50 days.

ARM 2: Participants maintain their usual diet for approximately 50 days.

All participants will complete a questionnaire and have their blood drawn at the beginning of the study (Day 0) and at the end of the study period (approximately Day 50).

Дати

Последна проверка: 12/31/2017
Първо изпратено: 07/12/2015
Очаквано записване подадено: 07/14/2015
Първо публикувано: 07/16/2015
Изпратена последна актуализация: 01/09/2018
Последна актуализация публикувана: 01/11/2018
Действителна начална дата на проучването: 08/31/2015
Приблизителна дата на първично завършване: 05/31/2016
Очаквана дата на завършване на проучването: 12/31/2017

Състояние или заболяване

Healthy

Интервенция / лечение

Dietary Supplement: Flaxseed (ground)

Фаза

-

Групи за ръце

ArmИнтервенция / лечение
Experimental: Flaxseed (ground)
Dietary Supplement: Flaxseed (ground)
2 tablespoons of ground flaxseed taken daily for approximately 50 days.
No Intervention: Usual diet

Критерии за допустимост

Възрасти, отговарящи на условията за проучване 57 Years Да се 57 Years
Полове, допустими за проучванеFemale
Приема здрави доброволциДа
Критерии

Inclusion Criteria:

1. Women residing in Toronto aged 57-64 years old, and post-menopausal.

Exclusion Criteria:

1. Consumers of flaxseed and soy (including supplements) in the past 6 months.

2. Consumers of sesame oil and sesame seeds in the past 6 months.

3. Women who took antibiotics orally in the past 6 months.

4. Women who took hormone replacement therapy or corticosteroids in the past month.

5. Non-English speaking.

6. Current chronic illnesses such as bowel disease (e.g. IBS - irritable bowel syndrome, or IBD - inflammatory bowel disease, such as Crohn's or ulcerative colitis), diabetes, heart disease (e.g. high cholesterol or high blood pressure and on medication for it), cancer, or another chronic illness.

7. Women who are currently taking blood thinners, such as Warfarin.

Резултат

Първични изходни мерки

1. Change in circulating levels of sex steroid hormones at Day 0 (baseline) compared with ~Day 50 (end of study period) [Day 0 and ~Day 50]

Вторични изходни мерки

1. Change in serum enterolignan levels at Day 0 (baseline) compared with ~Day 50 (end of study period) [Day 0 and ~Day 50]

Присъединете се към нашата
страница във facebook

Най-пълната база данни за лечебни билки, подкрепена от науката

  • Работи на 55 езика
  • Билкови лекове, подкрепени от науката
  • Разпознаване на билки по изображение
  • Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
  • Прочетете научни публикации, свързани с вашето търсене
  • Търсете лечебни билки по техните ефекти
  • Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания

Google Play badgeApp Store badge